Altius Minerals (OTCMKTS:ATUSF – Get Rating) had its price target hoisted by stock analysts at Canaccord Genuity Group from C$27.00 to C$28.00 in a report issued on Wednesday, The Fly reports. The firm currently has a “buy” rating on the stock.
Several other research firms have also recently issued reports on ATUSF. Scotiabank increased their price target on Altius Minerals from C$25.00 to C$26.00 in a research note on Wednesday, April 13th. TD Securities raised their target price on Altius Minerals from C$22.00 to C$29.00 in a research note on Monday, March 14th. Raymond James raised their target price on Altius Minerals from C$24.00 to C$26.00 in a research note on Wednesday. Finally, BMO Capital Markets increased their price target on Altius Minerals from C$22.00 to C$23.00 in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Altius Minerals currently has a consensus rating of “Buy” and a consensus target price of $25.17.
Shares of OTCMKTS:ATUSF traded down $0.40 on Wednesday, hitting $19.87. The company’s stock had a trading volume of 38,747 shares, compared to its average volume of 44,009. Altius Minerals has a 12 month low of $11.56 and a 12 month high of $20.36. The stock’s 50-day moving average is $18.33 and its two-hundred day moving average is $14.96.
Altius Minerals Company Profile (Get Rating)
Altius Minerals Corporation operates as a diversified mining royalty and streaming company in Canada, the United States, and Brazil. The company owns royalty and streaming interests in 12 operating mines covering copper, zinc, nickel, cobalt, iron ore, precious metals, potash, and thermal and metallurgical coal.
- Get a free copy of the StockNews.com research report on Altius Minerals (ATUSF)
- Highly Valued Abbot Laboratories Could Move Lower
- Baker Hughes, Another Buy-The-Dip Opportunity In Oilfield Services
- Netflix (NASDAQ: NFLX) Falls Back to 2018 Levels
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
Receive News & Ratings for Altius Minerals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altius Minerals and related companies with MarketBeat.com's FREE daily email newsletter.